Showing results (161-170 of 3,716) with videos related to

Sort By:
Pageof 372
Investigational New Drugs|July 1, 1989
Cytotoxicity of synthetic racemic ptilocaulin: a novel cyclic guanidineR L Ruben, B B Snider, F W Hobbs, et al.
Investigational New Drugs|July 1, 1989
Phase I clinical trial of doxorubicin and iproplatin combination chemotherapy in patients with breast cancerE S Casper, T Curley, T B Hakes
Investigational New Drugs|July 1, 1989
Phase I and pharmacokinetic study of SM-5887, a new anthracycline derivativeK Inoue, M Ogawa, N Horikoshi, et al.
Investigational New Drugs|December 9, 2016
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumorsNoboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada, et al.
Investigational New Drugs|February 12, 2017
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase CKhaldoun Almhanna, Maria Luisa Limon Miron, David Wright, et al.
Investigational New Drugs|March 30, 2017
A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumorsGun Min Kim, Tony Reid, Sang Joon Shin, et al.
Investigational New Drugs|April 13, 2017
Resistance to immunotherapy: clouds in a bright skyGérard Milano
Investigational New Drugs|September 1, 2019
A Phase 1 study of BAL101553, a novel tumor checkpoint controller targeting microtubules, administered as 48-h infusion in adult patients with advanced solid tumorsMarkus Joerger, Anastasios Stathis, Yannis Metaxas, et al.
Investigational New Drugs|August 9, 2019
Correction to: Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumorsPreeti Roy, Jasmine George, Smita Srivastava, et al.
Investigational New Drugs|August 21, 2019
Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapyTomoharu Yoshiya, Takahiro Mimae, Masaoki Ito, et al.
Pageof 372